hotspot -WSS

hotspot

author：explore 2025-09-06 02:15:08 - browse：3361

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： WATCH: Why do bright lights make us see spots?

WSS

Food makers to regulators: Ultra

A common UTI test for kids haunts adults as a traumatic 'nightmare'

What to make of Biden’s latest efforts on cancer research

No plane should take off without an EpiPen onboard

Mega Millions pot grows to $1.25 billion after no winner

New Covid vaccine is recommended for everyone 6 months or older

knowledge

hotspot

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Micronoma's microbiome cancer diagnostic approach under fire

Wildfire smoke exposes gaps in outdoor worker protections

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Malaria cases in Florida and Texas: Here’s what you need to know

What the US credit downgrade means for the economy, your finances

Apple is now the first public company to be valued at $3 trillion

Regeneron agrees to White House price limits on anti

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mitch McConnell episode has important public health takeaway

focus

FDA panel endorses Alnylam’s heart drug — after picking it apart

‘Oppenheimer’ and the risks of AI in health care

How to make the FDA’s new prescription one

Long Covid needs a new name — and a new frame

New Covid vaccine is recommended for everyone 6 months or older

What the airline industry can learn from medicine

hotspot

focus

hotspot

knowledge